SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9867758
Source:
http://linkedlifedata.com/resource/pubmed/id/9867758
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004364
,
umls-concept:C0010583
,
umls-concept:C0205082
,
umls-concept:C0205269
pubmed:issue
12
pubmed:dateCreated
1998-12-17
pubmed:abstractText
Immunoablative high-dose cyclophosphamide without stem-cell rescue induces durable, complete remission in most patients with aplastic anemia.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/AR43727
,
http://linkedlifedata.com/resource/pubmed/grant/CA15396
,
http://linkedlifedata.com/resource/pubmed/grant/CA70970
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-4819
pubmed:author
pubmed-author:BrodskyII
,
pubmed-author:BrodskyR ARA
,
pubmed-author:DangC VCV
,
pubmed-author:JonesR JRJ
,
pubmed-author:PetriMM
,
pubmed-author:SeifterE JEJ
,
pubmed-author:SmithB DBD
,
pubmed-author:SpivakJ LJL
,
pubmed-author:StylerMM
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
129
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1031-5
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9867758-Adult
,
pubmed-meshheading:9867758-Autoimmune Diseases
,
pubmed-meshheading:9867758-Cyclophosphamide
,
pubmed-meshheading:9867758-Drug Administration Schedule
,
pubmed-meshheading:9867758-Female
,
pubmed-meshheading:9867758-Humans
,
pubmed-meshheading:9867758-Immunosuppressive Agents
,
pubmed-meshheading:9867758-Male
,
pubmed-meshheading:9867758-Middle Aged
,
pubmed-meshheading:9867758-Prospective Studies
,
pubmed-meshheading:9867758-Remission Induction
,
pubmed-meshheading:9867758-Treatment Outcome
pubmed:year
1998
pubmed:articleTitle
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
pubmed:affiliation
Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Case Reports
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II